Since 2008, the Prevention, Care and Treatment (PCT) Programme at IDI has managed to provide high quality care and treatment to an average of 8,000 active HIV/AIDS patients.Special clinics have been established for special HIV infected populations, such as sero-discordant couples, adolescents, older adults, pregnant mothers, MARPs and those with non-communicable diseases. The number of patients requiring second and other complex forms of antiretroviral treatment has gradually increased, as IDI plays its role of a referral centre for more complicated cases within the national referral system. This has increasingly necessitated the transfer of more stable patients from the IDI Mulago clinic to clinics that have developed the necessary capacity (with IDI support) to provide quality HIV/AIDS care services.IDI has espoused ‘prevention through positives’ and clients are being encouraged to play a role in prevention, adherence, and stigma reduction, through a range of creative and empowering activities (musical; artistic; spiritual; entrepreneurial; social). At IDI, clients are called ‘Friends’ and are emerging as key players in the long term solution to the HIV/AIDS pandemic. This initiative is in keeping with the emerging Greater Involvement of People Living with HIV/AIDS (GIPA) movement.
The PCT Programme has also produced a series of innovative and replicable models of care, such as those relating to: task shifting (nurse and pharmacy-only visits); integrated HIV/TB clinic; integrated sexual and reproductive health services; and care and treatment for certain most-at-risk populations (commercial sex workers and long distance truck drivers).
The PCT and Research programmes have been closely intertwined; since 2008, the IDI clinic has established itself as a solid research platform, with the number of clinic-based research projects steadily rising. Linkage with the IDI Training Programme has also been strengthened; in addition, staff development has been fostered through regular continuing medical education (CME) activities such as; ‘switch’ meetings (focussing on regimen change for individual patients), journal clubs, case conferences and a Research Forum.
A major achievement has been the successful implementation of a clinic management system called ICEA (the Integrated Clinic Enterprise Application).
The PCT senior staff has also contributed to national policy development through participation on the sub-committees of the National ART Committee for HIV Drug Resistance and for adult antiretroviral therapy (ART).